Allogeneic CD19-targeted CAR-γδT cell infusion therapy

CAR-γδT cell therapy targeting CD19 · The First Affiliated Hospital of Soochow University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic CD19-targeted CAR-γδT cell infusion therapy, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia [EARLY_Phase 1]

See pricing